Pacific Biosciences of California Inc
(STU:P09)
€
2.319
0.068 (3.02%)
Market Cap: 639.11 Mil
Enterprise Value: 1.02 Bil
PE Ratio: 0
PB Ratio: 1.39
GF Score: 57/100 
Pacific Biosciences of California Inc at Goldman Sachs Healthcare Conference Transcript
Jun 13, 2023 / 03:00PM GMT
Release Date Price:
€12.66
(-1.25%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Thanks for joining us this morning. My name is Matt Sykes. I'm the life science tools and diagnostics analyst at Goldman Sachs. I have the pleasure of welcoming CEO of PacBio, Christian Henry, here to our conference this morning. Christian, thanks for coming.
Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director
Yes. Thank you. My commute was short today.
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Yes. We try to make it easy for you.
Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director
Thank you.
Questions & Answers
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Maybe I think it would be helpful for you to maybe set the stage for us, just talk about sort of the key
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers